within Pharmacolibrary.Drugs.ATC.N;

model N05CA12
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.0016666666666666668,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Reposal, with ATC code N05CA12, is a barbituric acid derivative (barbiturate) that was previously used as a sedative and hypnotic. It is no longer commonly used or approved for medical use today due to safety concerns and the availability of safer alternatives.</p><h4>Pharmacokinetics</h4><p>No primary pharmacokinetic studies or published PK parameters for reposal were identified. The following are general estimates based on pharmacokinetic profiles of similar barbiturates (sedative-hypnotics) in healthy adult individuals.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05CA12;
